![](/img/cover-not-exists.png)
The Efficacy and Effectiveness in HBA1C-Lowering is Dependent on Baseline Body Mass Index (BMI) for Sitagliptin but not Canagliflozin in the Treatment of Type 2 Diabetes Mellitus (T2DM)
Diels, J., Angermund, R., Schroeder, M., Worbes-Cerezo, M., Thompson, G.Volume:
17
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2014.08.639
Date:
November, 2014
File:
PDF, 62 KB
english, 2014